Terazosin-md

SKU: orb3174929

Description

Terazosin-md (compound TZ-md) is a derivative of Alfuzosin and Terazosin, functioning as an orally active α1-adrenergic receptor antagonist. It enhances mitochondrial metabolism, degrades various pathological protein deposits, and improves vascular endothelial cell function. Moreover, Terazosin-md has shown activity in mouse models of Alzheimer's disease. This compound can be utilized in the research of Alzheimer's disease, its complications, and disorders associated with protein aggregation and metabolic imbalances.

Key Properties

• CAS Number: 2423919-77-9
• MW: 386.45
• Formula: C₂₀H₂₆N₄O₄
• SMILES: O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=C2)CC1)C4OCCC4
• Target: Adrenergic Receptor,Mitochondrial Metabolism

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Adrenergic Receptor,Mitochondrial Metabolism